Evidence map›Paper›PMID 37842920›Full record

ArticleGut microbes2023

Emma Bergsten, Denis Mestivier, Francoise Donnadieu, Thierry Pedron, Caroline Barau, Landry Tsoumtsa Meda, Amel Mettouchi, Emmanuel Lemichez, Olivier Gorgette, Mathias Chamaillard and 6 more

Open access · goldAbstract read
In one paragraph

Article in Gut microbes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. IntratumoralScience advances · 2026
    Article
  10. Review
  11. Observational
  12. Article
  13. Review
  14. Frontiers in cellular and infection microbiology · 2026
    Review
  15. Article
  16. Article
  17. Article
  18. Colorectal cancer-associatedJournal of bacteriology · 2025
    Article
  19. Oral microbes and gastrointestinal cancers: new strategies and insights.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Emma BergstenUnité de Pathogénie Microbienne Moléculaire, INSERM U1202, Institut Pasteur, Paris, France.
Denis MestivierÉquipe universitaire EC2M3-EA7375, Université Paris- Est (UPEC), Créteil, France.
Francoise DonnadieuUnité de Pathogénie Microbienne Moléculaire, INSERM U1202, Institut Pasteur, Paris, France.
Thierry PedronUnité de Pathogénie Microbienne Moléculaire, INSERM U1202, Institut Pasteur, Paris, France.
Caroline BarauPlateforme de Ressources Biologiques, CHU Henri Mondor Assistance Publique Hôpitaux de Paris (APHP), Créteil, France.
Landry Tsoumtsa MedaUnité des Toxines Bactériennes, Université Paris Cité, CNRS UMR6047, INSERM U1306, Institut Pasteur, Paris, France.
Amel MettouchiUnité des Toxines Bactériennes, Université Paris Cité, CNRS UMR6047, INSERM U1306, Institut Pasteur, Paris, France.
Emmanuel LemichezUnité des Toxines Bactériennes, Université Paris Cité, CNRS UMR6047, INSERM U1306, Institut Pasteur, Paris, France.
Olivier GorgettePlateforme de Bio-Imagerie Ultrastructurale, Institut Pasteur, Université Paris Cité, Paris, France.
Mathias ChamaillardLaboratory of Cell Physiology, INSERM U1003, University of Lille, Lille, France.
Amaury VaysseBioinformatics and Biostatistics Hub, Institut Pasteur, Université Paris Cité, Paris, France.
Stevenn VolantBioinformatics and Biostatistics Hub, Institut Pasteur, Université Paris Cité, Paris, France.
Abiba DoukaniSorbonne Université, Inserm, Unité Mixte de Service Production et Analyse de données en Sciences de la Vie et en Santé, Paris, France.
Philippe J SansonettiUnité de Pathogénie Microbienne Moléculaire, INSERM U1202, Institut Pasteur, Paris, France.
Iradj SobhaniÉquipe universitaire EC2M3-EA7375, Université Paris- Est (UPEC), Créteil, France.
Giulia NigroUnité de Pathogénie Microbienne Moléculaire, INSERM U1202, Institut Pasteur, Paris, France.ORCID 0000-0002-1014-7394
Inserm · FRCentre National de la Recherche Scientifique · FRInstitut Pasteur · FRCentre Hospitalier Universitaire Henri-Mondor · FRUniversité Paris-Est Créteil · FR

Funding

Epigenetic mechanisms of carcinogenesis by Parvimonas micra, an oral cavity commensal turned colon cancer pathogenR01CA264048 · NCI · MAYO CLINIC ARIZONA · PI BOARDMAN, LISA ALLYN, GOUNARI, FOTINI · 2021 to 2025
$3.1M
NCI NIH HHS R01 CA264048
6 · The paper itself

Abstract

Recently, an intestinal dysbiotic microbiota with enrichment in oral cavity bacteria has been described in colorectal cancer (CRC) patients. Here, we characterize and investigate one of these oral pathobionts, the Gram-positive anaerobic coccus

Indexed as

Colorectal NeoplasmsGastrointestinal MicrobiomeBacillotaBacteriaHumanscolonic epithelial primary cellsColorectal cancerDNA methylationParvimonas micrapathobionts

Identifiers

PMID37842920
PMCPMC10580862
OpenAlexW4387660965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.